From: Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer: a systematic review
Author | Year | Study design | Endometrial Cancer Cases (n) | Overall result RR (95% CI) |
---|---|---|---|---|
Gottschau | 2015 | Registry cohort (Denmark) | 16 | 3.9 (2.2–6.3)a |
Shen | 2015 | Registry cohort (Taiwan) | 7 | 4.7 (1.6–14.1)a |
Barryb | 2014 | Meta-analysis | 1264 | 2.8 (1.3–6.0)a |
Haoulac | 2012 | Meta-analysis | 938 | 2.9 (1.5–5.5)a |
Brintond | 2010 | Cohort (US) | 15 | 2.0 (1.1–3.3)a |
Fearnleye | 2010 | Case control (Australia) | 156 | 2.2 (0.9–5.7) |
Chittendenf | 2009 | Meta-analysis | 667 | 2.7 (1.0–7.3)c |
Zucchetto | 2009 | Case–control (Italy) | 454 | 1.3 (0.7–2.2) |
Iatrakise | 2006 | Case–control (Greece) | 81 | 9.0 (0.5–176.0)a,g |
Pillayh | 2006 | Cross-sectional (UK) | 128 | 1.0 (0.4–2.7)a,c |
Niwa | 2000 | Case–control (Japan) | 136 | 8.9 (0.4–184.9)a,g |
Wild | 2000 | Cohort (UK) | 11 | 6.1 (1.0–36.9) |
Escobedo | 1991 | Case–control (US) | 437 | 5.4 (2.4–12.3)a |
Coulami | 1983 | Cohort (US) | 5 | 3.1 (1.1–7.3)a |